Annovis Bio, Inc.盘中异动早盘股价大跌5.19%报8.03美元

市场透视09-23

北京时间2024年09月23日23时06分，Annovis Bio, Inc.（ANVS.us）股票出现波动，股价快速下挫5.19%。截至发稿，该股报8.03美元/股，成交量5.4114万股，换手率0.41%，振幅5.69%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.02百万美元，每股收益-0.44美元，毛利0.00美元，市盈率-1.77倍。机构评级方面，在所有6家参与评级的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2469145481?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-23 23:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2469145481","market":"us","top_or_hot":-1,"title":"Annovis Bio, Inc.盘中异动 早盘股价大跌5.19%报8.03美元","media":"市场透视","content":"<div>\n<p>北京时间2024年09月23日23时06分，Annovis Bio, Inc.（ANVS.us）股票出现波动，股价快速下挫5.19%。截至发稿，该股报8.03美元/股，成交量5.4114万股，换手率0.41%，振幅5.69%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.02百万美元，每股收益-0.44美元，毛利0.00美元，市盈率-1.77倍。机构评级方面，在所有6家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323062098e3877b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Annovis Bio, Inc.盘中异动 早盘股价大跌5.19%报8.03美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnnovis Bio, Inc.盘中异动 早盘股价大跌5.19%报8.03美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-23 23:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323062098e3877b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年09月23日23时06分，Annovis Bio, Inc.（ANVS.us）股票出现波动，股价快速下挫5.19%。截至发稿，该股报8.03美元/股，成交量5.4114万股，换手率0.41%，振幅5.69%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.02百万美元，每股收益-0.44美元，毛利0.00美元，市盈率-1.77倍。机构评级方面，在所有6家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323062098e3877b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323062098e3877b&s=b","article_id":"2469145481","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323062098e3877b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2469145481","pubTimestamp":1727103980,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年09月23日23时06分，Annovis Bio, Inc.股票出现波动，股价快速下挫5.19%。截至发稿，该股报8.03美元/股，成交量5.4114万股，换手率0.41%，振幅5.69%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","ANVS":"Annovis Bio, Inc."},"translate_title":"Annovis Bio, Inc. stock fell 5.19% to $8.03 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANVS":1},"content_text":"北京时间2024年09月23日23时06分，Annovis Bio, Inc.（ANVS.us）股票出现波动，股价快速下挫5.19%。截至发稿，该股报8.03美元/股，成交量5.4114万股，换手率0.41%，振幅5.69%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.02百万美元，每股收益-0.44美元，毛利0.00美元，市盈率-1.77倍。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)、Cingulate Inc C/Wts 10/12/2026 (To Pur Com)、Neurosense Therapeutics Ltd C/Wts 10/11/2026 (To Pur Com)涨幅较大，Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为251.41%、46.54%、44.30%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025(To Pur Com)、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Black Diamond Therapeutics, Inc.，振幅分别为42.83%、42.78%、25.84%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。该公司管线产品有：Buntanetap 用于治疗慢性神经退行性疾病 - 包括 AD 和 PD； ANVS405治疗急性神经退行性疾病； 以及用于高级 AD 的 ANVS301。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2469145481"}

Annovis Bio, Inc.盘中异动 早盘股价大跌5.19%报8.03美元

精彩评论

Annovis Bio, Inc.盘中异动早盘股价大跌5.19%报8.03美元